Search Tag: sepsis detection

2025 14 Oct

  Biomarkers are essential tools in the emergency department for improving early detection, risk stratification, and patient management. This article reviews challenges in biomarker integration, the diagnostic and prognostic value of pancreatic stone protein (PSP), and the role of point-of-care solutions such as the abioSCOPE® in advancing personalised...Read more

2025 20 May

Artificial intelligence (AI) plays an evolving role in optimising sepsis management and SEP-1 compliance. Despite these advances, barriers persist, including alert fatigue, disparities in model performance across diverse settings, and regulatory hurdles in AI deployment. By integrating predictive models with structured team-based interventions, healthcare...Read more

2025 13 May

  The growing integration of digital technologies in the National Health Service (NHS) has enabled the transformation of traditional clinical protocols into digital tools, with sepsis screening standing as a critical area of innovation. Sepsis, a life-threatening response to infection, necessitates early identification and treatment to improve patient...Read more

2024 02 Oct

  Abionic, an emerging medical diagnostics company focused on rapid early detection technologies, announced today that its  IVD CAPSULE PSP  test has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to accelerate the  Time-to-Detection  of Sepsis. Already certified under the EU IVDR as of July 2022, this FDA clearance marks...Read more

2024 01 Oct

  Abionic SA has appointed Patrick Pestalozzi as CEO. With three decades of global experience in management consulting and entrepreneurship, Patrick has been instrumental in creating and developing deep-tech ventures. His diverse healthcare background positions him to lead Abionic's next growth phase. ICU Management & Practice interviewed Patrick...Read more